If your clinic hasn’t fully adjusted its recall process since last year, this is worth a closer look. From 1 July 2025, the Australian Government replaced the old GP Management Plan (GPMP) and Team Care Arrangement (TCA) items with a single GP Chronic Condition Management Plan (GPCCMP), tied directly to a patient’s MyMedicare registration. For general practice, it’s one of the more significant operational changes to chronic disease management in years and it has a direct, practical impact on how recall and review processes need to work.
Under the new framework, the previously separate GP Management Plan and Team Care Arrangement items have been retired in favour of a single GPCCMP structure. Patients registered with MyMedicare need to access their chronic condition management plan and reviews through the practice where they’re registered; patients who haven’t registered with MyMedicare can still access these services through their usual GP.
Two timelines matter here, and it’s easy to conflate them:
Before this change, a lapsed care plan review was primarily a claiming issue, a missed opportunity for the practice to bill correctly. Under the new framework, it’s also a patient access issue. A review that falls outside the 18-month window doesn’t just affect the practice’s records; it can affect whether the patient can keep accessing allied health services they’re relying on.
For practice managers, this changes the nature of the question “which patients are approaching their review window, and which have already passed it.” It’s no longer a nice-to-have report, it’s core to keeping patients connected to care they’re entitled to. And because MyMedicare registration determines which practice can deliver the plan, recall lists need to reflect a clinic’s actually-registered patients specifically, not just a generic “care plan due” flag.
This is exactly the kind of regulatory shift that makes a manually run recall list risky, not because staff aren’t capable, but because the compliance logic (registration status, review windows, transition timing, clinical eligibility) has more moving parts than the old system did. A recall process built around a single generic “due date” rule struggles to keep up with requirements that vary by registration status and are tied to a rolling 18-month clock per patient.
Coda connects directly to Best Practice and identifies patients who are overdue or high-risk based on the conditions your clinic defines, which means a requirement like the GPCCMP review window can be built directly into the criteria the system tracks, rather than recalculated manually every week. It reaches out to those patients automatically, follows up if there’s no response, and hands your reception team a call list only for the patients still outstanding.
If your clinic hasn’t yet reviewed how your recall process accounts for the new GPCCMP structure, it’s worth putting on the agenda well before more legacy patients reach the 2027 transition deadline.
© 2026 Coda Pty Ltd. All rights reserved.
Made in Australia.